Reconstituting MSH6 increases TMZ sensitivity in MSH6-null primary GBM cells, suggesting that mismatch repair defects are an important mechanism leading to resistance in GBM with inactive MGMT [108]. The gene discussed is MGMT; the disease is glioblastoma.